Annual Drug Patent Expirations for BAQSIMI
Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has sixty-seven patent family members in thirty-eight countries.
The generic ingredient in BAQSIMI is glucagon. One supplier is listed for this compound. Additional details are available on the glucagon profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
